Switzerland (CH)

Coreline Criteria for Inertial Particle Motion (2021) Rojo IB, Günther T Conference contribution Introduction to Vector Field Topology (2021) Günther T, Baeza Rojo I Conference contribution Room-Temperature On-Spin-Switching and Tuning in a Porphyrin-Based Multifunctional Interface (2021) Sturmeit HM, Cojocariu I, Windischbacher A, Puschnig P, Piamonteze C, Jugovac M, Sala A, et al. Journal article Association of quality of life (QOL) with overall survival (OS) in patients (pts) with HR+/HER2-advanced breast cancer (ABC) treated with ribociclib (RIB) plus endocrine therapy (ET) in the MONALEESA-3 (ML-3) and ML-7 trials (2021) Fasching P, Harbeck N, Jerusalem G, Colleoni MA, Neven P, Franke F, De Laurentiis M, et al. Conference contribution The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses (2021) Ruszniewski PB, Caplin ME, Kunz PL, Bodei L, Hendifar AE, Mittra E, Wolin EM, et al. Conference contribution PACIFIC-R real-world study: Treatment duration and interim analysis of progression-free survival in unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy (2021) Girard N, Smit HJM, Sibille A, Mcdonald F, Mornex F, Garassino MCC, Filippi AR, et al. Conference contribution Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptorepositive advanced breast cancer (ABC): Secondary and exploratory results of phase 3b RIBECCA study (2021) Decker T, Fasching P, Nusch A, Hartkopf A, Heinrich BJ, Kurbacher CM, Fuchs R, et al. Conference contribution Neoadjuvant giredestrant (GDC-9545) + palbociclib (palbo) vs anastrozole (A) plus palbo in post-menopausal women with oestrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC): Interim analysis of the randomised, open-label, phase II coopERA BC study (2021) Hurvitz SA, Park YH, Bardia A, Quiroga V, Lopez-Valverde V, Steinseifer J, Moore HM, et al. Conference contribution Antiochus III, Ptolemy IV, and Local Elites: Deal-Making Plitics at Its Peak (2021) Dreyer B, Gerardin F Book chapter / Article in edited volumes Cheap Talk and Cherry-Picking: What ClimateBert has to say on Corporate Climate Risk Disclosures (2021) Bingler JA, Kraus M, Leippold M Journal article, Original article